1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Existo S.r.l.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2019

Location

Milan Italy

Primary Industry

Medical Devices & Equipment

About

Based in Italy, and founded in 2019 by Fanny Boria, Existo, is part of the e-Novia Group and is a health-tech company that develops and manufactures lightweight wearable technology to assist people with disabilities. In April 2021, Existo raised EUR 600,000 in venture funding from new investor CDP Venture Capital. The company creates wearable technology to substitute for handicapped or diminished functionality of the human hand, which causes loss in handling things and materials. The equipment allows users to grip and hold objects as well as execute most jobs like a normal hand, and also provides physiotherapy to the arm. Furthermore, the company produces Sixto, a portable device that restores a person's correct motor patterns and redefines the concept of rehabilitation.
Current Investors
CDP Venture Capital, e-Novia SpA

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.existo.tech
Verticals
HealthTech, Manufacturing, Wearables & Quantified Self
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.